You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 39 No. 9, September 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (128)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Response to Phenelzine and Amitriptyline in Subtypes of Outpatient Depression

Eugene S. Paykel, MD, FRCP, FRCPEd, FRCPsych; Peter R. Rowan, MB, BS, MRCPsych; Robert R. Parker, MB, ChB, MPhil, MRCPsych, DObst RCOG; Ashok V. Bhat, MSc, FSS

Arch Gen Psychiatry. 1982;39(9):1041-1049.


Abstract



• Outpatients with depression and mixed anxiety-depression were treated for six weeks with phenelzine sulfate, amitriptyline hydrochloride, or placebo in a controlled trial. Both active drugs were superior to placebo and were closely comparable in efficacy. Interactions were examined between drug response and classifications based on three different usages of the term atypical depression: additional anxiety or phobic symptoms, atypical functional shift, and nonendogenous depression. Some additional related classifications were also included. There was a tendency for phenelzine to have stronger effects in patients with additional anxiety and without evidence of chronic characterological depression. However, interactions were relatively few. These findings suggest that the two classes of antidepressant affect similar clinical subgroups within the outpatient depressive spectrum, with only relatively weak differences.



Author Affiliations



From the Department of Psychiatry, St George's Hospital Medical School, London. Dr Parker is now with the Department of Psychiatry, Trinity College, Dublin.


Footnotes



Accepted for publication Jan 4, 1982.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Partial Validation of the Atypical Features Subtype of Major Depressive Disorder
Posternak and Zimmerman
Arch Gen Psychiatry 2002;59:70-76.
ABSTRACT | FULL TEXT  

Treatment approaches to therapy-resistant depression
Dinan
J Psychopharmacol 1995;9:199-204.
ABSTRACT  

The management of treatment-resistant affective disorder: clinical perspectives
Malizia and Bridges
J Psychopharmacol 1992;6:145-155.
 

Response to Phenelzine and Imipramine in Placebo Nonresponders With Atypical Depression: A New Application of the Crossover Design
Quitkin et al.
Arch Gen Psychiatry 1991;48:319-323.
ABSTRACT  

A Double Blind Trial of Moclobemide versus Amltrlptyllne in the Treatment of Depressive Disorders
Newburn et al.
Aust N Z J Psychiatry 1990;24:475-479.
ABSTRACT  

Atypical Depression, Panic Attacks, and Response to Imipramine and Phenelzine: A Replication
Quitkin et al.
Arch Gen Psychiatry 1990;47:935-941.
ABSTRACT  

Phenelzine and Imipramine in Mood Reactive Depressives: Further Delineation of the Syndrome of Atypical Depression
Quitkin et al.
Arch Gen Psychiatry 1989;46:787-793.
ABSTRACT  

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

Imipramine Treatment for Chronic Depression
Kocsis et al.
Arch Gen Psychiatry 1988;45:253-257.
ABSTRACT  

An Efficacy Study of Isocarboxazid and Placebo in Depression, and Its Relationship to Depressive Nosology
Davidson et al.
Arch Gen Psychiatry 1988;45:120-127.
ABSTRACT  

Antidepressant Specificity in Atypical Depression
Liebowitz et al.
Arch Gen Psychiatry 1988;45:129-137.
ABSTRACT  

Antidepressants: Their efficacy and place in therapy
Paykel
J Psychopharmacol 1988;2:105-118.
ABSTRACT  

The Validity of the Dexamethasone Suppression Test as a Marker for Endogenous Depression
Zimmerman et al.
Arch Gen Psychiatry 1986;43:347-355.
ABSTRACT  

The Validity of Four Definitions of Endogenous Depression: II. Clinical, Demographic, Familial, and Psychosocial Correlates
Zimmerman et al.
Arch Gen Psychiatry 1986;43:234-244.
ABSTRACT  

Somatic Symptoms in Primary Affective Disorder: Presence and Relationship to the Classification of Depression
Casper et al.
Arch Gen Psychiatry 1985;42:1098-1104.
ABSTRACT  

l-Deprenyl in Atypical Depressives
Quitkin et al.
Arch Gen Psychiatry 1984;41:777-781.
ABSTRACT  

Phenelzine v Imipramine in Atypical Depression: A Preliminary Report
Liebowitz et al.
Arch Gen Psychiatry 1984;41:669-677.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.